CNTXVSMXCT• 6 Months (Normalized)
CNTX vs MXCT (Context Therapeutics Inc. vs MaxCyte Inc.)
Showing Closing Date Range from Mar, 15 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CNTX Performance $0.35
-88.56%
Context Therapeutics Inc.
Normalized Baseline0.00%
MXCT Performance $1.16
+43.03%
MaxCyte Inc.
Normalized Baseline0.00%
Alpha Spread Margin MXCT LEADS
-131.59%
MXCT outperforming by 131.59%
CNTXMXCT
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CNTX MXCT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | CNTX Price | CNTX Gain (%) | MXCT Price | MXCT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.35 | -88.56% | $1.16 | +43.03% | -131.59% |
| Sep 10, 2026 | $0.37 | -88.04% | $1.19 | +46.73% | -134.77% |
| Sep 09, 2026 | $0.37 | -87.91% | $1.22 | +50.43% | -138.34% |
| Sep 08, 2026 | $0.38 | -87.71% | $1.28 | +57.21% | -144.92% |
| Sep 04, 2026 | $0.36 | -88.17% | $1.28 | +57.83% | -146.00% |
| Sep 03, 2026 | $0.36 | -88.14% | $1.26 | +55.36% | -143.50% |
| Sep 02, 2026 | $0.36 | -88.14% | $1.27 | +56.60% | -144.74% |
| Sep 01, 2026 | $0.36 | -88.10% | $1.24 | +52.90% | -141.00% |
| Aug 31, 2026 | $0.39 | -87.25% | $1.29 | +59.06% | -146.31% |
| Aug 28, 2026 | $0.38 | -87.45% | $1.22 | +50.43% | -137.88% |
| Aug 27, 2026 | $0.42 | -86.41% | $1.28 | +57.83% | -144.24% |
| Aug 26, 2026 | $0.42 | -86.14% | $1.31 | +61.53% | -147.67% |
| Aug 25, 2026 | $0.44 | -85.78% | $1.35 | +66.46% | -152.24% |
| Aug 24, 2026 | $0.47 | -84.80% | $1.39 | +71.39% | -156.19% |
| Aug 21, 2026 | $0.50 | -83.66% | $1.38 | +70.16% | -153.82% |
Page 1 of 9